Tiny heart probe may predict lung recovery
NCT ID NCT03763773
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a miniaturized ultrasound probe placed in the esophagus could help predict outcomes in 50 patients with acute respiratory distress syndrome (ARDS). The probe measures a blood vessel collapse index that may indicate heart strain. Researchers tracked how many days patients needed a breathing machine and survival rates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict how ARDS patients will recover, potentially guiding treatment decisions.
- What could go wrong
- This is a small, completed observational study with only 50 participants. The findings may not apply to all ARDS patients and need confirmation in larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Roger Salengro, CHU
Lille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Lung-Opening maneuver change a key injury marker in ARDS?
- Could simply sitting up ease breathing in severe lung failure?
- Could lung fluid proteins reveal a new way to track severe lung injury?
- Could a spirometer test guide breathing support in respiratory failure?
- Which ventilator setting saves more lungs? a Head-to-Head test
- Can a single antibody turn down the immune storm in ARDS?